Phenazopyridine for Confirmation of Ureteral Patency

Completed · Not applicable

Conditions studied: Cystoscopy

In brief

In this prospective, randomized trial subjects will be randomized to receive phenazopyridine or no medication prior to pelvic reconstructive procedures that use cystoscopy to confirm ureteral patency intraoperatively.

Key facts

Study ID

NCT02424149

Run by

Hartford Hospital

People needed

107

Starts

2015-04-01

Expected to finish

2016-01-01

Last updated by the study team

2016-12-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females only
• Planned surgical procedure where cystoscopy will be used to document ureteral urine flow
• Age > or = 18 years, no upper age limit
• Able and willing to consent

You may not qualify if…

• Planned surgical procedure where cystoscopy will not be used
• Planned surgical procedure where cystoscopy is used for a purpose other than documenting ureteral urine flow
• age <18 years
• pregnancy
• unable/unwilling to participate
• history of allergy or adverse reaction to phenazopyridine
• hepatic dysfunction
• known phenazopyridine hypersensitivity
• history of urologic surgery
• presence of ureteral stents prior to the planned surgical procedure
• concomitant suprapubic catheter placement

Where it is running

• Hartford Hospital — Hartford, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.